DSS Inc (DSS) - Total Liabilities
Based on the latest financial reports, DSS Inc (DSS) has total liabilities worth $66.02 Million USD as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore DSS operating cash flow to assess how effectively this company generates cash.
DSS Inc - Total Liabilities Trend (1997–2024)
This chart illustrates how DSS Inc's total liabilities have evolved over time, based on quarterly financial data. Check DSS financial resilience to evaluate the company's liquid asset resilience ratio.
DSS Inc Competitors by Total Liabilities
The table below lists competitors of DSS Inc ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Albion Resources Ltd
AU:ALB
|
Australia | AU$100.40K |
|
Archon Minerals Ltd
V:ACS
|
Canada | CA$68.39 Million |
|
Hydrofarm Holdings Group Inc
NASDAQ:HYFM
|
USA | $187.10 Million |
|
Conico Ltd
AU:CNJ
|
Australia | AU$293.96K |
|
Carmell Therapeutics Corporation
NASDAQ:CTCX
|
USA | $7.14 Million |
|
Joe Holding Bhd
KLSE:7096
|
Malaysia | RM75.27 Million |
|
Kane Biotech Inc
V:KNE
|
Canada | CA$3.48 Million |
|
Basin Energy Ltd
AU:BSN
|
Australia | AU$222.06K |
Liability Composition Analysis (1997–2024)
This chart breaks down DSS Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see DSS company net worth.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.32 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 4.65 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.72 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how DSS Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for DSS Inc (1997–2024)
The table below shows the annual total liabilities of DSS Inc from 1997 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | $73.74 Million | +5.37% |
| 2023-12-31 | $69.98 Million | -24.13% |
| 2022-12-31 | $92.23 Million | +9.13% |
| 2021-12-31 | $84.52 Million | +449.77% |
| 2020-12-31 | $15.37 Million | +96.02% |
| 2019-12-31 | $7.84 Million | +1.79% |
| 2018-12-31 | $7.71 Million | -39.06% |
| 2017-12-31 | $12.64 Million | -16.71% |
| 2016-12-31 | $15.18 Million | +26.83% |
| 2015-12-31 | $11.97 Million | +0.62% |
| 2014-12-31 | $11.90 Million | +32.88% |
| 2013-12-31 | $8.95 Million | +61.99% |
| 2012-12-31 | $5.53 Million | -24.52% |
| 2011-12-31 | $7.32 Million | -29.32% |
| 2010-12-31 | $10.36 Million | +131.39% |
| 2009-12-31 | $4.48 Million | -25.76% |
| 2008-12-31 | $6.03 Million | +42.35% |
| 2007-12-31 | $4.24 Million | +29.28% |
| 2006-12-31 | $3.28 Million | +198.87% |
| 2005-12-31 | $1.10 Million | +25.15% |
| 2004-12-31 | $876.22K | +24.17% |
| 2003-12-31 | $705.68K | +67.47% |
| 2002-12-31 | $421.38K | +248.54% |
| 2001-12-31 | $120.90K | -58.95% |
| 2000-12-31 | $294.52K | +13.59% |
| 1999-12-31 | $259.30K | +31.34% |
| 1998-12-31 | $197.43K | +33.72% |
| 1997-12-31 | $147.64K | -- |
About DSS Inc
DSS, Inc. operates in the product packaging, biotechnology, commercial lending, securities and investment management, and direct marketing businesses in the United States. The company manufactures, markets, and sells mailers, photo sleeves, custom folding cartons, and 3-dimensional direct mail solutions; and markets and distributes nutritional and personal care products. It also invests in or acq… Read more